Literature DB >> 21393062

Discriminating between latent and active tuberculosis with multiple biomarker responses.

Marc Frahm1, Neela D Goswami, Kouros Owzar, Emily Hecker, Ann Mosher, Emily Cadogan, Payam Nahid, Guido Ferrari, Jason E Stout.   

Abstract

We sought to identify biomarker responses to tuberculosis specific antigens which could 1) improve the diagnosis of tuberculosis infection and 2) allow the differentiation of active and latent infections. Seventy subjects with active tuberculosis (N = 12), latent tuberculosis (N = 32), or no evidence of tuberculosis infection (N = 26) were evaluated. We used the Luminex Multiplexed Bead Array platform to simultaneously evaluate 25 biomarkers in the supernatant of whole blood samples following overnight stimulation using the Quantiferon(®) Gold In-Tube kit. We defined the response to stimulation as the difference (within an individual patient) between the response to the pooled tuberculosis antigens and the negative control. IP-10 response was significantly higher in tuberculosis-infected (active or latent) subjects compared to the uninfected group (p < 0.0001). Among the 25 parameters, expression levels of IL-15 and MCP-1 were found to be significantly higher in the active tuberculosis group compared to the latent tuberculosis group (p = 0.0006 and 0.0030, respectively). When combined, IL-15 and MCP-1 accurately identified 83% of active and 88% of latent infections. The combination of IL-15 and MCP-1 responses was accurate in distinguishing persons with active tuberculosis from persons with latent tuberculosis in this study.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393062      PMCID: PMC3090479          DOI: 10.1016/j.tube.2011.02.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  27 in total

Review 1.  Tuberculosis.

Authors:  A D Harries; C Dye
Journal:  Ann Trop Med Parasitol       Date:  2006 Jul-Sep

2.  Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.

Authors:  J-S Lee; C-H Song; J-H Lim; K-S Lee; H-J Kim; J-K Park; T-H Paik; S-S Jung; E-K Jo
Journal:  Inflamm Res       Date:  2003-06       Impact factor: 4.575

3.  Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases.

Authors:  Ifedayo M O Adetifa; Martin O C Ota; Brigitte Walther; Abdulrahman S Hammond; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Philip C Hill
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

4.  Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.

Authors:  Roland Diel; Robert Loddenkemper; Karen Meywald-Walter; Stefan Niemann; Albert Nienhaus
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

5.  Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

Authors:  M Ruhwald; T Bodmer; C Maier; M Jepsen; M B Haaland; J Eugen-Olsen; P Ravn
Journal:  Eur Respir J       Date:  2008-08-06       Impact factor: 16.671

Review 6.  Advances in the diagnosis and treatment of tuberculosis.

Authors:  Payam Nahid; Madhukar Pai; Philip C Hopewell
Journal:  Proc Am Thorac Soc       Date:  2006

7.  The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands.

Authors:  I Sutherland; E Svandová; S Radhakrishna
Journal:  Tubercle       Date:  1982-12

8.  High level of discordant IGRA results in HIV-infected adults and children.

Authors:  A M Mandalakas; A C Hesseling; N N Chegou; H L Kirchner; X Zhu; B J Marais; G F Black; N Beyers; G Walzl
Journal:  Int J Tuberc Lung Dis       Date:  2008-04       Impact factor: 2.373

9.  A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.

Authors:  Pedro O Flores-Villanueva; Jorge A Ruiz-Morales; Chang-Hwa Song; Ludmila M Flores; Eun-Kyeong Jo; Marta Montaño; Peter F Barnes; Moises Selman; Julio Granados
Journal:  J Exp Med       Date:  2005-12-13       Impact factor: 14.307

10.  IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

Authors:  Morten Ruhwald; Morten Bjerregaard-Andersen; Paulo Rabna; Jesper Eugen-Olsen; Pernille Ravn
Journal:  BMC Res Notes       Date:  2009-02-04
View more
  47 in total

1.  Multicytokine detection improves latent tuberculosis diagnosis in health care workers.

Authors:  Pierre-Alain Rubbo; Nicolas Nagot; Vincent Le Moing; Marylène Brabet; Arnaud Bourdin; Erika Nogué; Karine Bolloré; Jean-Pierre Vendrell; Philippe Van De Perre; Edouard Tuaillon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.

Authors:  Takele Teklu; Keehwan Kwon; Biniam Wondale; Milkessa HaileMariam; Aboma Zewude; Girmay Medhin; Mengistu Legesse; Rembert Pieper; Gobena Ameni
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 3.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

Review 4.  Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls.

Authors:  Cinthya Ruiz-Tagle; Rodrigo Naves; María Elvira Balcells
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

5.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

Review 6.  Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis.

Authors:  S Mamishi; B Pourakbari; M Teymuri; P-A Rubbo; E Tuaillon; A A Keshtkar; S Mahmoudi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-04       Impact factor: 3.267

7.  Prokaryotic expression and in vitro functional analysis of IL-1β and MCP-1 from guinea pig.

Authors:  Vijaya R Dirisala; Amminikutty Jeevan; Lan H Ly; David N McMurray
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 8.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

9.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

10.  Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Nicole L Kushner; Sven Parsons; Blas Peixoto; Dorothy Fallows; Gilla Kaplan
Journal:  Am J Pathol       Date:  2012-09-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.